ATOS Insider Trading
Insider Ownership Percentage: 7.60%
Insider Buying (Last 12 Months): $51,250.00
Insider Selling (Last 12 Months): $0.00
Atossa Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at Atossa Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Atossa Therapeutics Share Price & Price History
Current Price: $0.65
Price Change: ▼ Price Decrease of -0.0219 (-3.25%)
As of 04/1/2025 05:00 PM ET
Atossa Therapeutics Insider Trading History
Atossa Therapeutics Institutional Trading History
Data available starting January 2016
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
Read More on Atossa Therapeutics
Volume
504,103 shs
Average Volume
981,925 shs
Market Capitalization
$84.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.2
Who are the company insiders with the largest holdings of Atossa Therapeutics?